1. Home
  2. CRIS vs SCOR Comparison

CRIS vs SCOR Comparison

Compare CRIS & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Curis Inc.

CRIS

Curis Inc.

N/A

Current Price

$1.13

Market Cap

20.6M

Sector

Health Care

ML Signal

N/A

Logo comScore Inc.

SCOR

comScore Inc.

N/A

Current Price

$4.99

Market Cap

101.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
CRIS
SCOR
Founded
2000
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
20.6M
101.6M
IPO Year
2000
2007

Fundamental Metrics

Financial Performance
Metric
CRIS
SCOR
Price
$1.13
$4.99
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
128.4K
44.4K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
91.57
127.37
EPS
N/A
N/A
Revenue
$9,898,000.00
$403,549,000.00
Revenue This Year
$27.10
$2.75
Revenue Next Year
$67.74
$7.30
P/E Ratio
N/A
N/A
Revenue Growth
31.50
1.02
52 Week Low
$0.18
$4.60
52 Week High
$6.74
$10.18

Technical Indicators

Market Signals
Indicator
CRIS
SCOR
Relative Strength Index (RSI) 22.99 42.11
Support Level $0.80 $4.60
Resistance Level $1.21 $7.72
Average True Range (ATR) 0.11 0.37
MACD 0.04 0.08
Stochastic Oscillator 9.44 43.84

Price Performance

Historical Comparison
CRIS
SCOR

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About SCOR comScore Inc.

comScore Inc is a information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. It create products using a data platform that combines information on digital platforms (connected televisions, mobile devices, tablets and computers), televisions, direct to consumer applications, and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. Its segments include Content & Ad Measurement and Research & Insight Solutions of which the Content & Ad Measurement segment derives the majority of the revenue.

Share on Social Networks: